MARVELD1 and bladder transitional cell carcinoma: MARVELD1 expression was significantly lower in most types of cancers, including bladder urothelial carcinoma (BLCA), breast invasive carcinoma (BRCA), endocervical adenocarcinoma (CESC), colon adenocarcinoma (COAD), kidney Chromophobe (KICH), liver hepatocellular carcinoma (LIHC), lung adenocarcinoma (LUAD), prostate adenocarcinoma (PRAD), and uterine corpus endometrial carcinoma (UCEC), than in their respective non-cancer tissues (Figure 1B, Supplementary Table 1).